Literature DB >> 11598077

Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.

N Vizcaíno1, R Kittelberger, A Cloeckaert, C M Marín, L Fernández-Lago.   

Abstract

The gene coding for the major outer membrane protein Omp31 was sequenced in five Brucella species and their biovars. Although the omp31 genes appeared to be highly conserved in the genus Brucella, nine nucleotide substitutions were detected in the gene of Brucella ovis compared to that of Brucella melitensis. As shown by differential binding properties of monoclonal antibodies (MAbs) to the two Brucella species, these nucleotide substitutions result in different antigenic properties of Omp31. The antigenic differences were also evidenced when sera from B. ovis-infected rams were tested by Western blotting with the recombinant B. melitensis or B. ovis Omp31 proteins. Twelve available sera reacted with recombinant B. ovis Omp31, but only four of them reacted with recombinant B. melitensis Omp31. These results validate previous evidence for the potential of Omp31 as a diagnostic antigen for B. ovis infection in rams and demonstrate that B. ovis Omp31, instead of B. melitensis Omp31, should be used to evaluate this point. The antigenic differences between the B. melitensis and B. ovis Omp31 proteins should also be taken into account when Omp31 is evaluated as a candidate for the development of subcellular vaccines against B. ovis infection. No reactivity against recombinant B. melitensis Omp31 was detected, by Western blotting, with sera from B. melitensis-infected sheep. Accordingly, Omp31 does not seem to be a good diagnostic antigen for B. melitensis infections in sheep. Two immunodominant regions were identified on the B. ovis Omp31 protein by using recombinant DNA techniques and specific MAbs. Sera from B. ovis-infected rams that reacted with the recombinant protein were tested by Western blotting against one of these immunodominant regions shown to be exposed at the bacterial surface. Only 4 of the 12 sera reacted, but with strong intensity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598077      PMCID: PMC100082          DOI: 10.1128/IAI.69.11.7020-7028.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Comparison of an enzyme-linked immunospecific assay (ELISA) with the cold complement fixation test for the serodiagnosis of Brucella ovis infection.

Authors:  D R Ris; K L Hamel; D L Long
Journal:  N Z Vet J       Date:  1984 Jan-Feb       Impact factor: 1.628

2.  DNA polymorphism at the omp-31 locus of Brucella spp.: evidence for a large deletion in Brucella abortus, and other species-specific markers.

Authors:  N Vizcaíno; J M Verger; M Grayon; M S Zygmunt; A Cloeckaert
Journal:  Microbiology (Reading)       Date:  1997-09       Impact factor: 2.777

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Species-specific sequences at the omp2 locus of Brucella type strains.

Authors:  T A Ficht; H S Husseinen; J Derr; S W Bearden
Journal:  Int J Syst Bacteriol       Date:  1996-01

5.  Enzyme-linked immunosorbent assay for Brucella ovis specific antibody in ram sera.

Authors:  T L Spencer; G W Burgess
Journal:  Res Vet Sci       Date:  1984-03       Impact factor: 2.534

6.  Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.

Authors:  R Kittelberger; D S Diack; N Vizcaíno; M S Zygmunt; A Cloeckaert
Journal:  Vet Microbiol       Date:  1998-01-16       Impact factor: 3.293

7.  Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

Authors:  N Vizcaíno; A Cloeckaert; M S Zygmunt; G Dubray
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay.

Authors:  A Cloeckaert; P de Wergifosse; G Dubray; J N Limet
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

9.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Polynucleotide homologies of Brucella deoxyribonucleic acids.

Authors:  B H Hoyer; N B McCullough
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

View more
  15 in total

1.  Comparative diagnostic evaluation of OMP31 gene based TaqMan® real-time PCR assay with visual LAMP assay and indirect ELISA for caprine brucellosis.

Authors:  Suman Saini; V K Gupta; K Gururaj; D D Singh; R V S Pawaiya; N K Gangwar; A K Mishra; Deepak Dwivedi; Dimple Andani; Ashok Kumar; T K Goswami
Journal:  Trop Anim Health Prod       Date:  2017-06-21       Impact factor: 1.559

2.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Quorum-sensing and BvrR/BvrS regulation, the type IV secretion system, cyclic glucans, and BacA in the virulence of Brucella ovis: similarities to and differences from smooth brucellae.

Authors:  Ana I Martín-Martín; Pilar Sancho; María Jesús de Miguel; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

4.  Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.

Authors:  Maria Clausse; Alejandra G Díaz; Andrés E Ibañez; Juliana Cassataro; Guillermo H Giambartolomei; Silvia M Estein
Journal:  Clin Vaccine Immunol       Date:  2014-10-22

5.  Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.

Authors:  Patricia Seco-Mediavilla; Jean-Michel Verger; Maggy Grayon; Axel Cloeckaert; Clara M Marín; Michel S Zygmunt; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis.

Authors:  Paola Caro-Hernández; Luis Fernández-Lago; María-Jesús de Miguel; Ana I Martín-Martín; Axel Cloeckaert; María-Jesús Grilló; Nieves Vizcaíno
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

7.  Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.

Authors:  Juliana Cassataro; Karina Pasquevich; Laura Bruno; Jorge C Wallach; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Molecular typing of Brucella species isolates from Human and livestock bloods in Isfahan province.

Authors:  Ebtehaj Pishva; Rasoul Salehi; Akbar Hoseini; Ali Kargar; Fatemeh Emani Taba; Maryam Hajiyan; Reza Fadaei; Javad Ramezanpour
Journal:  Adv Biomed Res       Date:  2015-05-29

9.  Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.

Authors:  Pilar Sancho; Carmen Tejedor; Rebeca S Sidhu-Muñoz; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

Review 10.  Analyzing the molecular mechanism of lipoprotein localization in Brucella.

Authors:  Shivani Goolab; Robyn L Roth; Henriette van Heerden; Michael C Crampton
Journal:  Front Microbiol       Date:  2015-10-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.